Robust Registration Pipeline Will Unlock Further Market Expansion

AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Published
31 Jan 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
₹1,128.40
12.2% undervalued intrinsic discount
08 Aug
₹990.40
Loading
1Y
79.1%
7D
-10.5%

Author's Valuation

₹1.1k

12.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on30 Jul 25
Fair value Increased 43%

The sharp upward revision in Sharda Cropchem's analyst price target reflects stronger expectations for profitability, as shown by a higher net profit margin, and increased valuation confidence, as indicated by a rising future P/E, resulting in a new target of ₹1128. What's in the News Board meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2025.

Shared on01 May 25
Fair value Decreased 9.87%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.